Vice President, General Manager, Americas Region

Founder & Executive Chairman

Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer

Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term S...

Medison and Ipsen Announces Health Canada Approves Bylvay?? for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

Health Canada Approves Bylvay™ (odevixibat) for the treatment of cholestatic pruritus in patients with Alagille Syndrome

Senior Director, Corporate Development

Medison Pharma is dedicated to offering hope to patients with rare and severe diseases through innovative therapies. They are seeking a Senior Director, Head of Corporate Development to lead valuation and transaction execution that aligns with the company's long-term growth strategy in the pharmaceutical industry.

Sign up with Google

Sign in with Google